China Medipharm Insights - January 2000

 

Regular Price: USD 1,000

Special Price USD 700

30% OFF

* Required Fields

Regular Price: USD 1,000

Special Price USD 700

PAY BY INVOICE

Be the first to review this product

Table of Contents

China Medipharm Insights - January 2000, China Medipharm InsightsCMI’s Review of 1999: Regulatory Changes Overshadow Other Events in China’s Pharmaceutical Market in 1999CMI’s Review of 1999: Regulatory Changes Overshadow Other Events in China’s Pharmaceutical Market in 1999Market GrowthForeign OperationsCOMPANY PROFILEAllergan (Hangzhou) Commences OperationSK&F Vows to Become OTC Market Leader in ChinaXinhua Chemferm ExpandedSino-Korean Tianjin Shin Poong Pharma EstablishedShanghai Squibb to Set Record in ExportsShenyang Feilong Loses Lawsuit Against SDANew Production Line For Infusions Into OperationHebei Wellcome Profits Grow 100%Technology Adds Momentum to Harbin General PharmaCitric Acid Extraction Project Passed EvaluationXinhua Pharma Rises in ExportHuayi Passes ISO9002 CertificationZhejiang Pharma Industrial Co Ltd EstablishedWuhan Jianmin Embraces High TechnologyTenth Workshop In Lukang Reaches GMP StandardsProduct NewsAmino Acid Calcium Chelate Developed in ShanghaiHismanal Tablet 3mg Marketed Penicillin K Granted FDA CertificateNew Clarithromycin Preparation MarketedAipuliete Launched Into MarketWanglong Ant Pill Into Scale ProductionHuman Fibrous Protein Gel DevelopedCompound Ranitidine Capsule DevelopedNew Oral Progestagen For Fetus Keeping Brought In ChinaNew Anticancer DevelopedJinzhou Jiutai Obtains Approval of U.S. FDAWeisu Allowed Into the EU MarketMajor Breakthrough in Hepatitis C Vaccine ResearchDiagnostic Reagent for Initial Cancer MarketedMethionine Racemization Technology Passes EvaluationMarket Analysis of Import Drug Markets in ChinaMarket Analysis of Import Drug Markets in ChinaImport Drug Markets in 1999Leading Import DrugsMarket Trends in Year 2000Pharmaceutical MarketChinese Chemical Drugs See GrowthMarket Analysis and PredictionOver The CounterRx/OTC Implementation Sped up in ChinaOTC Symbol ReleasedEvaluation And Registration of OTC Drug Roll OutsA Glance at the OTC Drugstore TrialNews in BriefJoint Venture Drugstores to be Tried in ChinaExtra Drug Income Must Return to Local Health AuthoritiesImplementation of Report System for Adverse Drug ReactionsReassessment of Drug Pricing by State Development and Planning CommissionState Drug-Safety Evaluation and Monitoring Center Foundation LaidNew Trend in Drug RegistrationQ1-Q3 Data On Pharmaceutical Industry in 1999Projections for 2000 Drug Market Order Was ImprovedIllegal Drug-Trade Markets Closed in Shanxi ProvincePrices of Drugs Lowered in HainanFujian Cuts Drug Prices a 3rd TimePrices of Drugs Lowered in GansuChongqing Adjusted Medical Fee Scheme On-Line Auction of Biopharmaceutical Technology




Keyword1

Keyword2

Keyword3

Related Research

Release Date : 08-Dec-17

Region : Asia Pacific

Release Date : 06-Dec-17

Region : Asia Pacific

Release Date : 27-Nov-17

Region : Asia Pacific

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.